Isabelle Sbille, UCB Biopharma SRL - Qepler Summits And Conferences

Isabelle Sbille

Associate director- Material Safety Expert (E&L)
UCB Biopharma SRL
With a unique combination of expertise in biology and chemistry, UCB is a global biopharma focusing on severe diseases in two therapeutic areas – CNS and Immunology.

Related Sessions:

3rd Annual Extractables &
Leachables Summit 2023

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 13 Jun 2023
  • Virtual,
  • Pharma
Day 2: Wednesday, 14 June 2023
CASE STUDY: Challenge for Industry with new USP665/1665
  • Risk Assessment Methodology (Upstream, Downstream process)
  • Analysis of regulation and Requirements
  • Key Challenge and experience from USP 1665
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.